| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/CIRCULATIONAHA.107.188965 |
| P698 | PubMed publication ID | 18391114 |
| P50 | author | Harlan M. Krumholz | Q28211478 |
| Emelia J. Benjamin | Q28754501 | ||
| George A. Mensah | Q37392484 | ||
| Gregg C. Fonarow | Q38543909 | ||
| Jagat Narula | Q56021238 | ||
| Daniel Levy | Q88264418 | ||
| P2093 | author name string | James B Young | |
| American Heart Association Council on Cardiovascular Nursing | |||
| American Heart Association Council on Clinical Cardiology | |||
| Douglas D Schocken | |||
| Yuling Hong | |||
| American Heart Association Council on Epidemiology and Prevention | |||
| Quality of Care and Outcomes Research Interdisciplinary Working Group | |||
| Functional Genomics and Translational Biology Interdisciplinary Working Group | |||
| American Heart Association Council on High Blood Pressure Research | |||
| Eileen Stuart Shor | |||
| P2860 | cites work | Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. | Q43816619 |
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heart failure | Q181754 |
| circulatory system | Q11068 | ||
| health care quality | Q17003063 | ||
| P304 | page(s) | 2544-2565 | |
| P577 | publication date | 2008-04-07 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Int | |
| P478 | volume | 117 |
| Q93088071 | 18 F-Labeled Derivatives of Irbesartan for Angiotensin II Receptor PET Imaging |
| Q92384431 | 20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study |
| Q40311948 | A Patient-Specific Computational Fluid Dynamic Model for Hemodynamic Analysis of Left Ventricle Diastolic Dysfunctions. |
| Q30828094 | A comparison of risk factors for mortality from heart failure in Asian and non-Asian populations: an overview of individual participant data from 32 prospective cohorts from the Asia-Pacific Region |
| Q44670964 | A semi-automated method for patient-specific computational flow modelling of left ventricles |
| Q34248473 | AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model |
| Q43658607 | ABCD's of Heart Failure: Echo-ing through the First Stage |
| Q37087291 | Absolute and attributable risks of heart failure incidence in relation to optimal risk factors |
| Q48742279 | Amount or intensity? Potential targets of exercise interventions in patients with heart failure with preserved ejection fraction |
| Q38044305 | Anticoagulation in heart failure: current status and future direction |
| Q41509582 | Artificial Cardiac Muscle with or without the Use of Scaffolds. |
| Q92643169 | Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury |
| Q36602874 | Association of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study. |
| Q26801725 | Association of Physical Activity or Fitness With Incident Heart Failure: A Systematic Review and Meta-Analysis |
| Q33880289 | Association of glucose metabolism with diastolic function along the diabetic continuum |
| Q34324724 | Association of obesity in early adulthood and middle age with incipient left ventricular dysfunction and structural remodeling: the CARDIA study (Coronary Artery Risk Development in Young Adults) |
| Q37556302 | Associations Between Blood Pressure and Outcomes Among Blacks in the Jackson Heart Study |
| Q58510237 | Avances en mecánica computacional para el diagnóstico y tratamiento de la enfermedad cardiovascular |
| Q94337976 | Beta‐blockers for heart failure |
| Q30984630 | Bone marrow cell therapy after acute myocardial infarction. Back to bench, or ready for an outcome trial |
| Q35716354 | CXCR4 Antagonism Attenuates the Development of Diabetic Cardiac Fibrosis |
| Q42717705 | Ca/Calmodulin-dependent Protein Kinase II in Heart Failure |
| Q26999872 | Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias |
| Q28070075 | Cardiometabolic Syndrome and Increased Risk of Heart Failure |
| Q58791389 | Cardioprotective Effects of High-Density Lipoprotein Beyond its Anti-Atherogenic Action |
| Q30692600 | Cardiovascular Health Status and Incidence of Heart Failure in the Framingham Offspring Study |
| Q34324812 | Charting a roadmap for heart failure biomarker studies |
| Q39097788 | Chocolate intake and incidence of heart failure: Findings from the Cohort of Swedish Men. |
| Q24604087 | Chocolate intake and incidence of heart failure: a population-based prospective study of middle-aged and elderly women |
| Q35070830 | Clinician's guide to the updated ABCs of cardiovascular disease prevention |
| Q37369709 | Coffee consumption and risk of heart failure in men: an analysis from the Cohort of Swedish Men. |
| Q30585473 | Combining knowledge and data driven insights for identifying risk factors using electronic health records |
| Q38666884 | Comorbidity of atrial fibrillation and heart failure |
| Q43899878 | Comparison of three commercially available softwares for measuring left ventricular perfusion and function by gated SPECT myocardial perfusion imaging |
| Q90627860 | Computational Model Predicts Paracrine and Intracellular Drivers of Fibroblast Phenotype After Myocardial Infarction |
| Q37192583 | Consistency with the DASH diet and incidence of heart failure |
| Q28646775 | Contribution of Major Lifestyle Risk Factors for Incident Heart Failure in Older Adults: The Cardiovascular Health Study |
| Q36010987 | Cost Burden of Potentially Preventable Hospitalizations for Cardiovascular Disease and Diabetes for Asian Americans, Pacific Islanders, and Whites in Hawai'i |
| Q39193265 | Cross-Talk Between Insulin Signaling and G Protein-Coupled Receptors |
| Q37688179 | Current treatment of heart failure in the USA. |
| Q92191695 | Customisation and validation of a low-volume plasma renin activity immunoassay: Enabling of regulatory compliant determination in paediatric trials |
| Q33993428 | DASH eating pattern is associated with favorable left ventricular function in the multi-ethnic study of atherosclerosis |
| Q35571144 | Diabetes and the risk of heart failure |
| Q58698076 | Diabetic Cardiomyopathy: Current and Future Therapies. Beyond Glycemic Control |
| Q28087715 | Diastolic dysfunction |
| Q35315085 | Diastolic dysfunction is associated with cardiac fibrosis in the senescence-accelerated mouse |
| Q33968568 | Dietary glycemic index, dietary glycemic load, and incidence of heart failure events: a prospective study of middle-aged and elderly women |
| Q44029205 | Dietary pattern and mortality in Japanese elderly patients with type 2 diabetes mellitus: does a vegetable- and fish-rich diet improve mortality? An explanatory study |
| Q51128620 | Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease. |
| Q33733517 | Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. |
| Q38642413 | Ectopy on a Single 12-Lead ECG, Incident Cardiac Myopathy, and Death in the Community |
| Q48116252 | Effect of bariatric surgery on heart failure. |
| Q39322673 | Effect of eplerenone in patients with heart failure and reduced ejection fraction: potential effect modification by abdominal obesity: Insight from the EMPHASIS-HF trial |
| Q24630778 | Epidemiology and risk profile of heart failure |
| Q37318509 | Epidemiology of Heart Failure in Korea: Present and Future |
| Q38685834 | Epidemiology of heart failure: the prevalence of heart failure and ventricular dysfunction in older adults over time. A systematic review |
| Q57202595 | Estimated urinary sodium excretion and risk of heart failure in men and women in the EPIC-Norfolk study |
| Q37152270 | Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23. |
| Q89495782 | Expression of microRNA-214 and galectin-3 in peripheral blood of patients with chronic heart failure and its clinical significance |
| Q36602987 | Extended prediction rule to optimise early detection of heart failure in older persons with non-acute shortness of breath: a cross-sectional study |
| Q64096693 | Factors Associated with Postoperative Pain among Patients after Cardiac Surgery in the Tertiary Care Teaching Hospital of Karachi, Pakistan |
| Q55100725 | Fatigue and physical activity after myocardial infarction. |
| Q28395992 | Fatty fish, marine omega-3 fatty acids and incidence of heart failure |
| Q58127115 | Fibroblast Growth Factor-23 and Heart Failure With Reduced Versus Preserved Ejection Fraction: MESA |
| Q28389253 | Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men |
| Q37538031 | Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association |
| Q53396197 | Gated SPECT: what's the ideal method to measure LVEF? |
| Q95260866 | Genetics of inherited cardiomyopathies in Africa |
| Q55241461 | Geographic Variation in Heart Failure Mortality and Its Association With Hypertension, Diabetes, and Behavioral-Related Risk Factors in 1,723 Counties of the United States. |
| Q33710663 | Glucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure |
| Q28290417 | Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy |
| Q34284599 | Habitual coffee consumption and risk of heart failure: a dose-response meta-analysis |
| Q48164792 | Health behavior and adherence to treatment for sleep breathing disorder in the patient with heart failure |
| Q34627340 | Healthy lifestyle and decreasing risk of heart failure in women: the Women's Health Initiative observational study |
| Q104473374 | Heart failure after myocardial infarction: incidence and predictors |
| Q38826590 | Heart failure and kidney dysfunction: epidemiology, mechanisms and management |
| Q37622587 | Heart failure burden and therapy |
| Q36928523 | Heart failure in South America |
| Q36928506 | Heart failure in South Asia |
| Q36928528 | Heart failure in sub-Saharan Africa |
| Q38960765 | Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes |
| Q42199698 | Heart failure: preventing disease and death worldwide |
| Q41627722 | High-density lipoprotein protects cardiomyocytes from oxidative stress via the PI3K/mTOR signaling pathway |
| Q35058809 | High-normal albuminuria and risk of heart failure in the community |
| Q26739723 | How Biomaterials Can Influence Various Cell Types in the Repair and Regeneration of the Heart after Myocardial Infarction |
| Q92024783 | How dietary patterns affect left ventricular structure, function and remodelling: evidence from the Kardiovize Brno 2030 study |
| Q38311622 | Identification and visualization of stimulus-specific transcriptional activity in cardiac hypertrophy in mice |
| Q64062233 | Impact of medical therapy for cardiovascular disease on left ventricular diastolic properties and remodeling |
| Q38764889 | Implanting CRT via Endo-Cardiac Route When Tricuspid Valve is Metallic |
| Q33761879 | Incidental cardiac findings on computed tomography imaging of the thorax |
| Q49556091 | Incremental Prognostic Value of Conventional Echocardiography in Patients with Acutely Decompensated Heart Failure |
| Q37811036 | Individual and Joint Associations of Obesity and Physical Activity on the Risk of Heart Failure |
| Q43983833 | Inequalities in heart failure in older men: prospective associations between socioeconomic measures and heart failure incidence in a 10-year follow-up study. |
| Q37090971 | Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology |
| Q37412632 | Integration of medical therapy and mechanical circulatory support in the management of acute heart failure |
| Q24185982 | Ivabradine as adjuvant treatment for chronic heart failure |
| Q24201614 | Ivabradine as adjuvant treatment for chronic heart failure |
| Q57061787 | Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice |
| Q38706209 | Life's Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. |
| Q37576108 | Low-density lipoprotein in the setting of congestive heart failure: is lower really better? |
| Q38376619 | Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cot |
| Q38044254 | Mechanisms and consequences of inflammatory signaling in the myocardium |
| Q39528114 | Mediterranean diet score and left ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis |
| Q42945928 | Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy |
| Q34357369 | Multimarker approach for the prediction of heart failure incidence in the community |
| Q37923971 | Myocardial regeneration in heart failure: integrated development of biological therapeutic approaches |
| Q37641749 | Myocardial remodeling after infarction: the role of myofibroblasts |
| Q47894878 | N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study |
| Q35989680 | NT-proBNP and Its Correlation with In-Hospital Mortality in the Very Elderly without an Admission Diagnosis of Heart Failure. |
| Q64355425 | National Rate of Tobacco and Substance Use Disorders Among Hospitalized Heart Failure Patients |
| Q47113843 | New Antihyperglycemic Drugs and Heart Failure: Synopsis of Basic and Clinical Data. |
| Q38246170 | New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction |
| Q34375466 | New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes |
| Q37552283 | Northern Territory Heart Failure Initiative-Clinical Audit (NTHFI-CA)-a prospective database on the quality of care and outcomes for acute decompensated heart failure admission in the Northern Territory: study design and rationale. |
| Q43184339 | Novel Therapeutic Strategies for Reducing Right Heart Failure Associated Mortality in Fibrotic Lung Diseases |
| Q41856322 | Novel strategies for the treatment of heart failure |
| Q40620222 | Nursing Diagnosis for People With Heart Failure Based on the Hemodynamic Profiles |
| Q37620445 | Omega-3 fatty acids and heart failure |
| Q37142428 | Patients with cardiac disease: Changes observed through last decade in out-patient clinics |
| Q38963920 | Persistent change in cardiac fibroblast physiology after transient ACE inhibition |
| Q38657314 | Persistent phenotypic shift in cardiac fibroblasts: impact of transient renin angiotensin system inhibition |
| Q42740793 | Polymorphisms present in G-protein-coupled receptor kinases and their effect on β-blocker treatment |
| Q35185676 | Potentially Preventable Hospitalizations for Congestive Heart Failure Among Asian Americans and Pacific Islanders in Hawai'i |
| Q36992652 | Predicting Heart Failure With Preserved and Reduced Ejection Fraction: The International Collaboration on Heart Failure Subtypes |
| Q91071243 | Predicting adults likely to develop heart failure using readily available clinical information: An analysis of heart failure incidence using the NHEFS |
| Q35040761 | Predictors of incident heart failure in a large insured population: a one million person-year follow-up study |
| Q36067664 | Predictors of knowledge gains using simulation in the education of prelicensure nursing students |
| Q35855340 | Predictors of medication nonadherence differ among black and white patients with heart failure |
| Q30375842 | Prevalence and Risk Factors of Heart Failure with Preserved Ejection Fraction: A Population-Based Study in Northeast China. |
| Q28742689 | Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES) |
| Q48529037 | Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy |
| Q30486992 | Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion |
| Q51635429 | Prevalence, Prognosis, and Therapeutic Implications of Unrecognized Left Ventricular Systolic Dysfunction in Patients With Anemia and Chronic Kidney Disease |
| Q35994802 | Preventing Heart Failure in Inflammatory and Immune Disorders |
| Q64076693 | Prevention of Heart Failure in Hypertension-Disentangling the Role of Evolving Left Ventricular Hypertrophy and Blood Pressure Lowering: The ALLHAT Study |
| Q37978190 | Prevention of heart failure in the elderly: when, where and how to begin? |
| Q37777297 | Primary prevention of heart failure: an update |
| Q40217312 | Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart Failure. |
| Q41140893 | Prognostic role of N-terminal pro-brain natriuretic peptide in asymptomatic hypertensive and diabetic patients in primary care: impact of age and gender : Results from the PROBE-HF study |
| Q37734294 | Proinflammatory cytokines in heart failure: double-edged swords |
| Q35353825 | Race-ethnic and sex differences in left ventricular structure and function: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. |
| Q36085697 | Racial differences in clinical treatment and self-care behaviors of adults with chronic heart failure |
| Q33692727 | Racial differences in incident heart failure among young adults |
| Q28260201 | Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity |
| Q33526464 | Rationale and design of a randomised controlled trial evaluating the effectiveness of an exercise program to improve the quality of life of patients with heart failure in primary care: The EFICAR study protocol |
| Q34324771 | Rationale and design of the GUIDE-IT study: Guiding Evidence Based Therapy Using Biomarker Intensified Treatment in Heart Failure |
| Q58510252 | Recent Advances in the Application of Computational Mechanics to the Diagnosis and Treatment of Cardiovascular Disease |
| Q37587495 | Recent advances in the application of computational mechanics to the diagnosis and treatment of cardiovascular disease |
| Q37415591 | Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years |
| Q48449156 | Relation of epicardial fat thickness to the severity of heart failure in patients with nonischemic dilated cardiomyopathy |
| Q36693904 | Relations of lipid concentrations to heart failure incidence: the Framingham Heart Study |
| Q34032117 | Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community |
| Q41069120 | Relationship of Office and Ambulatory Blood Pressure With Left Ventricular Global Longitudinal Strain |
| Q36956711 | Role of Mitochondrial Oxidative Stress in Glucose Tolerance, Insulin Resistance, and Cardiac Diastolic Dysfunction |
| Q33708076 | Screening and Treatment for Subclinical Hypertensive Heart Disease in Emergency Department Patients With Uncontrolled Blood Pressure: A Cost-effectiveness Analysis |
| Q34994289 | Socioeconomic status, Medicaid coverage, clinical comorbidity, and rehospitalization or death after an incident heart failure hospitalization: Atherosclerosis Risk in Communities cohort (1987 to 2004). |
| Q39960934 | Sociology meets genetics: sociogenetic implications for future management of hypertension and heart failure |
| Q35118559 | Speed and duration of walking and other leisure time physical activity and the risk of heart failure: a prospective cohort study from the Copenhagen City Heart Study |
| Q30486604 | Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial |
| Q34329885 | Symptom variability, not severity, predicts rehospitalization and mortality in patients with heart failure |
| Q33591746 | Symptoms associated with an abnormal echocardiogram in elderly primary care hypertension patients. |
| Q36069269 | Systolic blood pressure levels among adults with hypertension and incident cardiovascular events: the atherosclerosis risk in communities study |
| Q28281608 | Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties |
| Q39749357 | The 6-min walk test: is it an effective method for evaluating heart failure therapies? |
| Q42916626 | The Beneficial Effect of n-3 Polyunsaturated Fatty Acids on Doxorubicin-induced Chronic Heart Failure in Rats |
| Q49505221 | The Effects of Tai Chi Training in Patients with Heart Failure: A Systematic Review and Meta-Analysis |
| Q34024341 | The association of hemoglobin a1c with incident heart failure among people without diabetes: the atherosclerosis risk in communities study |
| Q42154665 | The dilemma of implantable cardioverter-defibrillator therapy in the geriatric population |
| Q42665675 | The effects of good glycaemic control on left ventricular and coronary endothelial functions in patients with poorly controlled Type 2 diabetes mellitus |
| Q34343385 | The novel biomarker growth differentiation factor 15 in heart failure with normal ejection fraction |
| Q34514327 | The potentially modifiable burden of incident heart failure due to obesity: the atherosclerosis risk in communities study |
| Q38023271 | The role of TWEAK/Fn14 in cardiac remodeling |
| Q38281750 | The war against heart failure: the Lancet lecture |
| Q37238641 | Through thick and thin: a circulating growth factor inhibits age-related cardiac hypertrophy |
| Q38951112 | Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition |
| Q34089713 | Transforming growth factor β receptor 1 is a new candidate prognostic biomarker after acute myocardial infarction |
| Q50533414 | Transplantation of SNAP-treated adipose tissue-derived stem cells improves cardiac function and induces neovascularization after myocardium infarct in rats |
| Q37765902 | Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents |
| Q82692507 | Treatment of asymptomatic left ventricular dysfunction |
| Q28079391 | Twenty years of anti-HER2 therapy-associated cardiotoxicity |
| Q24650649 | Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction |
| Q60049738 | Validation of the MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) heart failure risk score and the effect of adding natriuretic peptide for predicting mortality after discharge in hospitalized patients with heart failure |
| Q24308124 | Validation of the health ABC heart failure model for incident heart failure risk prediction: the Cardiovascular Health Study |
| Q35848591 | Vitamin E supplementation and the risk of heart failure in women |
| Q46745145 | Voluntary Exercise Improves Cardiac Function and Prevents Cardiac Remodeling in a Mouse Model of Dilated Cardiomyopathy |
| Q82976542 | α-Linolenic acid, linoleic acid and heart failure in women |
Search more.